Blog

RHD Action Awards Eldoret Chapter Small Grant Award

Launched this year, the RHD Action Small Grants Program funded five activities in low-and-middle income countries across the globe to support groups who are already addressing the work of RHD and to bring the work of key RHD stakeholders under the RHD Action banner. Successful applicants were awarded $2,000 with the expectation that the activity would be completed within six-months.

Ms Dilys Kemunto Nyariki, a sixth-year medical student at Moi University, School of Medicine in Eldoret, Kenya was the project lead on behalf of the Eldoret Chapter of the Young Professionals Chronic Disease Network (YPCDN) for the project entitled, “Hearts to Hearts: A Rheumatic Heart Disease (RHD) Awareness Campaign.” 

 

 

Read more
RHD Action Awards Eldoret Chapter Small Grant Award
RHD Action Awards Eldoret Chapter Small Grant Award

YP-CDN Partners in Youth Innovation Lab held at WHO Financing Conference in Copenhagen, Denmark

The WHO Global Dialogue was part of the informal process leading up to the United Nations General Assembly Third High-Level Meeting on the Prevention and Control of Non-communicable Diseases in September 2018. It was co-organized by the World Health Organization and the Government of Denmark and supported by the Organisation for Economic Co-operation and Development, the World Diabetes Foundation, the International Federation of Pharmaceutical Manufacturers and Associations, the World Economic Forum and the NCD Alliance. 
 
Read more
YP-CDN Partners in Youth Innovation Lab held at WHO Financing Conference in Copenhagen, Denmark
YP-CDN Partners in Youth Innovation Lab held at WHO Financing Conference in Copenhagen, Denmark

Inappropriate prescribing among Ethiopian cardiovascular patients using STOPP/START criteria.

Cardiovascular disorders are among the leading chronic illnesses. Medications play a pivotal role to control the signs, symptoms and progression of these disorders. However, the outcome of the management is depend on the delivery of the right regimen to the right patient. A recent prospective evaluation of prescriptions among Ethiopian cardiovascular patients have identified that approximately, two-thirds of elderly cardiovascular patients encountered potentially inappropriate prescription which is more significant.  The magnitude of inappropriate prescription is aggravated by long hospital stay and large number of medications. Therefore, it is essential to evaluate patients’ medications during hospital stay to reduce the burden of potentially inappropriate prescription. Members of the young professionals’ chronic diseases network-Gondar chapter have been engaged in the acquisition, analysis and interpretation of results on this project.

Readers are advised to visit the following link to access the full text of the article.

http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0195949

Inappropriate prescribing among Ethiopian cardiovascular patients using STOPP/START criteria.
Inappropriate prescribing among Ethiopian cardiovascular patients using STOPP/START criteria.

Older patients’ perception of deprescribing in resource-limited settings

As people get older, Chronic diseases become common causes of diseases, having multimorbidity. This will lead to have polypharmacy in older patients contributing to the regimen complexity which can affects patients medication adherence, prescribing quality, adverse drug reaction, health related quality of life and death. All these necessitates a clinical intervention such as deprescribing (reducing inappropriate poly-pharmacy). But such intervention should consider older patients decision/willingness in medication discontinuation process as it may affects the ultimate their clinical outcome. Though this has been extensively explored in developed countries, no attempt was made to explore willingness of older adults with chronic disease for discontinuation of inappropriate medications. 

Young Professionals Chronic Disease Network (YP-CDN) Ethiopia chapter, has worked with older patients living with chronic diseases and has identified their priorities for advocacy, and were used as an input for this research project.

Medication safety for older patients with chronic disease requires deprescription of the inappropriate prescriptions. 

Find the full article at http://bmjopen.bmj.com/content/8/4/e020590

 

Older patients’ perception of deprescribing in resource-limited settings
Older patients’ perception of deprescribing in resource-limited settings

Read the blog at Young Professionals Chronic Disease Network
Blog
Home